Physical Obstruction of Nasal Cavities With Subsequent Asphyxia, Causes Lethality of Rats in an Acute Inhalation Study With Hydrophobic HMDZ Surface-Treated Synthetic Amorphous Silica (SAS).


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 29 03 2022
accepted: 12 05 2022
entrez: 20 6 2022
pubmed: 21 6 2022
medline: 22 6 2022
Statut: epublish

Résumé

The aim of the present study was to understand the mechanism of lethality associated with high dose inhalation of a low-density hydrophobic surface-treated SAS observed in some acute inhalation studies. It was demonstrated that physical obstruction of the upper respiratory tract (nasal cavities) caused the effects observed. Hydrophobic surface-treated SAS was inhaled (flow-past, nose-only) by six Wistar rats (three males and three females) in an acute toxicity study at a concentration of ~500 mg/m

Identifiants

pubmed: 35719607
doi: 10.3389/fpubh.2022.907078
pmc: PMC9204156
doi:

Substances chimiques

Aerosols 0
Silicon Dioxide 7631-86-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

907078

Informations de copyright

Copyright © 2022 Krueger, Weber, Warfving, Vitali, Nolde, Schuster, Bruer, Creutzenberg, Wessely, Stintz, Moise and Kellert.

Déclaration de conflit d'intérêts

NK and TS are employed by Evonik Operations GmbH. KW, NW, and AV are employed by AnaPath Services GmbH. JN is employed by Grace Europe Holding GmbH. GG and OC are employed by Fraunhofer Institute for Toxicology and Experimental Medicine. BW and MS are employed by Technische Universität Dresden. VM is employed by Cabot Corporation. MK is employed by Wacker Chemie AG.

Références

J Forensic Sci. 2000 Nov;45(6):1274-7
pubmed: 11110181
Exp Toxicol Pathol. 2004 Jul;55(6):433-49
pubmed: 15384249
Forensic Sci Int. 1996 Jun 28;80(1-2):71-8
pubmed: 8690324
Exp Toxicol Pathol. 2003 Sep;55(2-3):91-106
pubmed: 14620530
Fundam Appl Toxicol. 1981 Jul-Aug;1(4):309-12
pubmed: 6764423
Vet Pathol. 2016 Sep;53(5):1037-48
pubmed: 27084399
Toxicol Pathol. 2011 Feb;39(2):337-47
pubmed: 21422260
Exp Toxicol Pathol. 2004 Jul;55(6):413-31
pubmed: 15384248

Auteurs

Nils Krueger (N)

Evonik Operations GmbH, Smart Materials, Hanau, Germany.

Klaus Weber (K)

AnaPath Services GmbH, Liestal, Switzerland.

Nils Warfving (N)

AnaPath Services GmbH, Liestal, Switzerland.

Alex Vitali (A)

AnaPath Services GmbH, Liestal, Switzerland.

Jürgen Nolde (J)

Grace Europe Holding GmbH, Worms, Germany.

Tobias B Schuster (TB)

Evonik Operations GmbH, Smart Materials, Hanau, Germany.

Gustav Gerd Bruer (GG)

Department of Inhalation Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine (Fh-ITEM), Hannover, Germany.

Otto Creutzenberg (O)

Department of Inhalation Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine (Fh-ITEM), Hannover, Germany.

Benno Wessely (B)

Institute of Process Engineering and Environmental Technology, Research Group Mechanical Process Engineering, Technische Universität Dresden, Dresden, Germany.

Michael Stintz (M)

Institute of Process Engineering and Environmental Technology, Research Group Mechanical Process Engineering, Technische Universität Dresden, Dresden, Germany.

Valerie Moise (V)

Cabot Corporation, Corporate SHE - Product Safety and Toxicology, Loncin, Belgium.

Marco Kellert (M)

Wacker Chemie AG, Burghausen, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH